HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Serum lysophospholipase D/autotaxin may be a new nutritional assessment marker: study on prostate cancer patients.

AbstractBACKGROUND:
It is now established that the bioactive lipid lysophosphatidic acid (LPA) contributes to cancer initiation, progression and metastasis, including those of prostate cancer. LPA is produced in the serum and plasma mainly by conversion from lysophospholipids through the action of lysophospholipase D (lysoPLD), which is identical to the soluble form of autotaxin (ATX) originally isolated as a tumour cell motility-stimulating factor. In this study, we evaluated the usefulness of lysoPLD/ATX activity as a diagnostic marker.
METHODS:
The serum lysoPLD activity, assessed by measuring choline liberation from the substrate lysophosphatidylcholine, was measured in patients with prostate cancer and compared with the concentrations of prostate-specific antigen (PSA) and conventional nutritional assessment markers.
RESULTS:
The serum lysoPLD activity in prostate cancer patients was not statistically different from that in the controls. Consistent with this, there was no correlation between the serum lysoPLD activity and the serum PSA concentrations. However, the lysoPLD/ATX activity did decrease after operation in the prostate cancer patients and seemed to reflect the postoperative damage or the nutritional status.
CONCLUSIONS:
We postulate that while the serum lysoPLD/ATX may not be a marker of prostate cancer, it promises to instead be a new marker of nutritional status.
AuthorsKazuhiro Nakamura, Takumi Takeuchi, Ryunosuke Ohkawa, Shigeo Okubo, Hiromitsu Yokota, Minoru Tozuka, Junken Aoki, Hiroyuki Arai, Hitoshi Ikeda, Noriko Ohshima, Tadaichi Kitamura, Yutaka Yatomi
JournalAnnals of clinical biochemistry (Ann Clin Biochem) Vol. 44 Issue Pt 6 Pg. 549-56 (Nov 2007) ISSN: 0004-5632 [Print] England
PMID17961310 (Publication Type: Comparative Study, Evaluation Study, Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Biomarkers, Tumor
  • Hemoglobins
  • Multienzyme Complexes
  • Prealbumin
  • Serum Albumin
  • Phosphoric Diester Hydrolases
  • Phosphodiesterase I
  • alkylglycerophosphoethanolamine phosphodiesterase
  • Prostate-Specific Antigen
  • Pyrophosphatases
Topics
  • Biomarkers, Tumor (analysis, blood)
  • Hemoglobins (analysis)
  • Humans
  • Male
  • Multienzyme Complexes (analysis, blood)
  • Nutrition Assessment
  • Nutrition Disorders (blood, diagnosis, etiology)
  • Phosphodiesterase I (analysis, blood)
  • Phosphoric Diester Hydrolases (analysis, blood)
  • Prealbumin (analysis)
  • Prostate-Specific Antigen (blood)
  • Prostatic Neoplasms (blood, complications)
  • Pyrophosphatases (analysis, blood)
  • Serum Albumin (analysis)
  • Time Factors

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: